CareCloud
CCLDNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $2.63 Prior regular-session close from the quote source.
- $2.56–$2.68 Regular-session low and high so far today.
- 535.8K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $1.67–$3.81 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own CCLD if CareCloud is a small healthcare revenue-cycle-management turnaround whose business value depends on proving that generative AI plus low-cost offshore delivery can restart growth while keeping cash conversion high.
CCLD price history
Loading recent earnings…
Investment thesis
What must happen next
CareCloud’s technology-enabled RCM and generative AI offering remains valuable enough to providers to regain volume after the prior revenue contraction, rather than being displaced by bundled EHR/RCM suites or in-house automation.HoldingMateriality: High
GAAP annual revenue increased to $120.5 million in FY2025 from $110.8 million in FY2024 after two years of decline. If provider demand is truly returning, revenue can compound from the current base; if not, the 2025 rebound is only a temporary stabilization.
Watch: Epic, Oracle Health, athenahealth, eClinicalWorks or other EHR/practice-management platforms bundle revenue-cycle tools tightly enough that physician groups no longer need a separate CareCloud service layer.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual revenue increased to $120.5 million in FY2025 from $110.8 million in FY2024 after two years of decline.
Open source ↗CareCloud’s specialized offshore workforce and automation can convert RCM service demand into operating leverage instead of merely adding labor cost.StrengtheningMateriality: High
GAAP annual operating income improved to $11.3 million in FY2025 from $9.1 million in FY2024. This determines whether revenue growth is economically valuable or just low-margin services volume.
Watch: Offshore wage inflation, turnover or service-quality problems force CareCloud to shift work back onshore.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating income improved to $11.3 million in FY2025 from $9.1 million in FY2024.
Open source ↗The RCM services model remains cash-generative because collections, support and workflow services require less incremental cash investment than the accounting earnings suggest.StrengtheningMateriality: Medium
GAAP annual operating cash flow was positive in every year shown from FY2021 through FY2025. Sustained operating cash flow gives CareCloud room to invest, reduce obligations or return value without relying on external financing.
Watch: Healthcare providers demand longer payment terms or performance-based contracts that delay CareCloud’s cash collections.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating cash flow was positive in every year shown from FY2021 through FY2025.
Open source ↗CareCloud’s balance sheet can support the turnaround without forcing distress financing, provided liabilities do not rise faster than the cash engine.StrengtheningMateriality: Medium
Total liabilities were $28.1 million at FY2025 year-end versus $36.1 million at FY2023 year-end and $42.9 million at FY2021 year-end. A manageable liability load lets the company invest in product and sales; a stressed balance sheet would transfer upside away from common shareholders.
Watch: Management uses debt or preferred securities to fund acquisitions before the organic turnaround is proven.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Total liabilities were $28.1 million at FY2025 year-end versus $36.1 million at FY2023 year-end and $42.9 million at FY2021 year-end.
Open source ↗The operating turnaround must flow through to common shareholders; otherwise preferred claims, dilution, impairments or other below-operating-income leakage will cap per-share value.HoldingMateriality: Medium
GAAP diluted EPS improved to $0.10 in FY2025 from negative $0.28 in FY2024 and negative $4.11 in FY2023. Owners need cash earnings per share, not just better operating income, for the equity thesis to compound.
Watch: Preferred dividends, conversions, warrants or equity issuance dilute common shareholders while operating income improves.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP diluted EPS improved to $0.10 in FY2025 from negative $0.28 in FY2024 and negative $4.11 in FY2023.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
CareCloud’s technology-enabled RCM and generative AI offering remains valuable enough to providers to regain volume after the prior revenue contraction, rather than being displaced by bundled EHR/RCM suites or in-house automation. If provider demand is truly returning, revenue can compound from the current base; if not, the 2025 rebound is only a temporary stabilization.
CareCloud’s specialized offshore workforce and automation can convert RCM service demand into operating leverage instead of merely adding labor cost. This determines whether revenue growth is economically valuable or just low-margin services volume.
The RCM services model remains cash-generative because collections, support and workflow services require less incremental cash investment than the accounting earnings suggest. Sustained operating cash flow gives CareCloud room to invest, reduce obligations or return value without relying on external financing.
CareCloud’s balance sheet can support the turnaround without forcing distress financing, provided liabilities do not rise faster than the cash engine. A manageable liability load lets the company invest in product and sales; a stressed balance sheet would transfer upside away from common shareholders.
The operating turnaround must flow through to common shareholders; otherwise preferred claims, dilution, impairments or other below-operating-income leakage will cap per-share value. Owners need cash earnings per share, not just better operating income, for the equity thesis to compound.
All standing thesis claims
Original report summary
CareCloud is a small healthcare revenue-cycle-management turnaround whose business value depends on proving that generative AI plus low-cost offshore delivery can restart growth while keeping cash conversion high.
Bull case and bear case
Bull case and bear case for CareCloud
Where the evidence on CareCloud stands: Holding on the latest evidence (Nov 6, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.
Bull case: what the evidence supports
CareCloud’s technology-enabled RCM and generative AI offering remains valuable enough to providers to regain volume after the prior revenue contraction, rather than being displaced by bundled EHR/RCM suites or in-house automation.
CareCloud’s specialized offshore workforce and automation can convert RCM service demand into operating leverage instead of merely adding labor cost.
The RCM services model remains cash-generative because collections, support and workflow services require less incremental cash investment than the accounting earnings suggest.
CareCloud’s balance sheet can support the turnaround without forcing distress financing, provided liabilities do not rise faster than the cash engine.
The operating turnaround must flow through to common shareholders; otherwise preferred claims, dilution, impairments or other below-operating-income leakage will cap per-share value.
Bear case: what would count against it
Epic, Oracle Health, athenahealth, eClinicalWorks or other EHR/practice-management platforms bundle revenue-cycle tools tightly enough that physician groups no longer need a separate CareCloud service layer.
Offshore wage inflation, turnover or service-quality problems force CareCloud to shift work back onshore.
Healthcare providers demand longer payment terms or performance-based contracts that delay CareCloud’s cash collections.
Thesis-Break Engine
Thesis-break watch · CareCloud
Loading the break-condition record for CareCloud.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
CareCloud filed an SEC 8-K on 2026-11-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
CareCloud filed an SEC 8-K on 2026-09-29: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
CareCloud filed an SEC 8-K on 2026-08-06: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Epic, Oracle Health, athenahealth, eClinicalWorks or other EHR/practice-management platforms bundle revenue-cycle tools tightly enough that physician groups no longer need a separate CareCloud service layer.
- Offshore wage inflation, turnover or service-quality problems force CareCloud to shift work back onshore.
- Healthcare providers demand longer payment terms or performance-based contracts that delay CareCloud’s cash collections.
- Management uses debt or preferred securities to fund acquisitions before the organic turnaround is proven.
- Preferred dividends, conversions, warrants or equity issuance dilute common shareholders while operating income improves.
CCLD news
Loading headlines…
Financial statements
CCLD income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.